Activation of permeabilized HL60 cells by vanadate. Evidence for divergent signalling pathways.
The possible role of tyrosine phosphorylation in the activation of granulocytic HL60 cells was examined using vanadate, a phosphotyrosine phosphatase inhibitor. Treatment of permeabilized cells with micromolar concentrations of vanadate resulted in a substantial accumulation of tyrosine-phosphorylated proteins, detected by immunoblotting. At comparable concentrations, vanadate was also found to elicit an NADPH-dependent burst of oxygen utilization. Actin assembly, studied using 7-nitrobenz-2-oxa-1,3-diazole (NBD)-phallacidin, was similarly stimulated by vanadate, though considerably higher concentrations were required to observe this effect. In contrast with these responses, the secretion of lysozyme was not stimulated by vanadate, nor did vanadate affect calcium-induced secretion. Therefore, accumulation of tyrosine-phosphorylated proteins is associated with stimulation of some, but not all, of the responses characteristic of granulocytic cell activation. This indicates that the effects of vanadate are selective and suggests divergence of the signalling pathways leading to the individual effectors.
Division of Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada.
S
S
Trudel
G P
GP
Downey
S
S
Grinstein
M R
MR
Pâquet
D000199:Actins / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000546:Amanitins; D002118:Calcium / Q000494:pharmacology; D002463:Cell Membrane Permeability; D005089:Exocytosis; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D006160:Guanosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D015151:Immunoblotting; D015473:Leukemia, Promyelocytic, Acute / Q000378:metabolism*; D009113:Muramidase / Q000378:metabolism; D009249:NADP / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D019000:Phosphotyrosine; D011108:Polymers; D015398:Signal Transduction; D013873:Thionucleotides / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000378:metabolism; D014638:Vanadates / Q000494:pharmacology*
D000199:Actins; D000546:Amanitins; D011108:Polymers; D013873:Thionucleotides; D019000:Phosphotyrosine; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D014638:Vanadates; D014443:Tyrosine; D009249:NADP; C028877:7-nitrobenz-2-oxa-1,3-diazole-phallacidin; D006160:Guanosine Triphosphate; D000255:Adenosine Triphosphate; D009113:Muramidase; D002118:Calcium